These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 20351091)
21. Long noncoding RNA ELDR promotes cell cycle progression in normal oral keratinocytes through induction of a CTCF-FOXM1-AURKA signaling axis. Sur S; Steele R; Ko BCB; Zhang J; Ray RB J Biol Chem; 2022 May; 298(5):101895. PubMed ID: 35378133 [TBL] [Abstract][Full Text] [Related]
22. MnSOD promotes tumor invasion via upregulation of FoxM1-MMP2 axis and related with poor survival and relapse in lung adenocarcinomas. Chen PM; Wu TC; Shieh SH; Wu YH; Li MC; Sheu GT; Cheng YW; Chen CY; Lee H Mol Cancer Res; 2013 Mar; 11(3):261-71. PubMed ID: 23271813 [TBL] [Abstract][Full Text] [Related]
23. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Wang Z; Banerjee S; Kong D; Li Y; Sarkar FH Cancer Res; 2007 Sep; 67(17):8293-300. PubMed ID: 17804744 [TBL] [Abstract][Full Text] [Related]
24. Two-fold elevation of expression of FoxM1 transcription factor in mouse embryonic fibroblasts enhances cell cycle checkpoint activity by stimulating p21 and Chk1 transcription. Tan Y; Chen Y; Yu L; Zhu H; Meng X; Huang X; Meng L; Ding M; Wang Z; Shan L Cell Prolif; 2010 Oct; 43(5):494-504. PubMed ID: 20887555 [TBL] [Abstract][Full Text] [Related]
25. FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion. Zheng Y; Guo J; Zhou J; Lu J; Chen Q; Zhang C; Qing C; Koeffler HP; Tong Y BMC Med Genomics; 2015 Aug; 8():49. PubMed ID: 26264222 [TBL] [Abstract][Full Text] [Related]
26. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. Calvisi DF; Pinna F; Ladu S; Pellegrino R; Simile MM; Frau M; De Miglio MR; Tomasi ML; Sanna V; Muroni MR; Feo F; Pascale RM Gut; 2009 May; 58(5):679-87. PubMed ID: 19136513 [TBL] [Abstract][Full Text] [Related]
27. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells. Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104 [TBL] [Abstract][Full Text] [Related]
28. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells. Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279 [TBL] [Abstract][Full Text] [Related]
29. FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. Bellelli R; Castellone MD; Garcia-Rostan G; Ugolini C; Nucera C; Sadow PM; Nappi TC; Salerno P; Cantisani MC; Basolo F; Gago TA; Salvatore G; Santoro M Endocr Relat Cancer; 2012 Oct; 19(5):695-710. PubMed ID: 22919068 [TBL] [Abstract][Full Text] [Related]
30. CXCL12-induced upregulation of FOXM1 expression promotes human glioblastoma cell invasion. Wang S; Zhang S; Li J; Xu X; Weng Y; Zheng M; Ouyang L; Li F Biochem Biophys Res Commun; 2014 Apr; 447(1):1-6. PubMed ID: 24561124 [TBL] [Abstract][Full Text] [Related]
31. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression. Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012 [TBL] [Abstract][Full Text] [Related]
32. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway. Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652 [TBL] [Abstract][Full Text] [Related]
34. FoxM1 and its association with matrix metalloproteinases (MMP) signaling pathway in papillary thyroid carcinoma. Ahmed M; Uddin S; Hussain AR; Alyan A; Jehan Z; Al-Dayel F; Al-Nuaim A; Al-Sobhi S; Amin T; Bavi P; Al-Kuraya KS J Clin Endocrinol Metab; 2012 Jan; 97(1):E1-E13. PubMed ID: 22049175 [TBL] [Abstract][Full Text] [Related]
35. FoxM1 regulates growth factor-induced expression of kinase-interacting stathmin (KIS) to promote cell cycle progression. Petrovic V; Costa RH; Lau LF; Raychaudhuri P; Tyner AL J Biol Chem; 2008 Jan; 283(1):453-460. PubMed ID: 17984092 [TBL] [Abstract][Full Text] [Related]
36. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. Gemenetzidis E; Bose A; Riaz AM; Chaplin T; Young BD; Ali M; Sugden D; Thurlow JK; Cheong SC; Teo SH; Wan H; Waseem A; Parkinson EK; Fortune F; Teh MT PLoS One; 2009; 4(3):e4849. PubMed ID: 19287496 [TBL] [Abstract][Full Text] [Related]
37. FOXM1 is a therapeutic target for high-risk multiple myeloma. Gu C; Yang Y; Sompallae R; Xu H; Tompkins VS; Holman C; Hose D; Goldschmidt H; Tricot G; Zhan F; Janz S Leukemia; 2016 Apr; 30(4):873-82. PubMed ID: 26648534 [TBL] [Abstract][Full Text] [Related]
38. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway. Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057 [TBL] [Abstract][Full Text] [Related]
39. The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells. Madureira PA; Varshochi R; Constantinidou D; Francis RE; Coombes RC; Yao KM; Lam EW J Biol Chem; 2006 Sep; 281(35):25167-76. PubMed ID: 16809346 [TBL] [Abstract][Full Text] [Related]
40. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer. McGovern UB; Francis RE; Peck B; Guest SK; Wang J; Myatt SS; Krol J; Kwok JM; Polychronis A; Coombes RC; Lam EW Mol Cancer Ther; 2009 Mar; 8(3):582-91. PubMed ID: 19276163 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]